BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33106998)

  • 41. Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3
    Sun X; Xu Q; Zeng L; Xie L; Zhao Q; Xu H; Wang X; Jiang N; Fu P; Sang M
    Cancer Med; 2020 Nov; 9(22):8685-8700. PubMed ID: 33040485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3β/Snail signaling pathway.
    Jin J; Zhang Z; Zhang S; Chen X; Chen Z; Hu P; Wang J; Xie C
    Mol Cell Endocrinol; 2018 Feb; 461():155-164. PubMed ID: 28893569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma.
    Lin J; Nong LL; Li MQ; Yang FC; Wang SH; Liu MJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4673-4679. PubMed ID: 31210293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
    An HT; Yoo S; Ko J
    Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
    Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
    Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway.
    Liang Y; Zhang T; Shi M; Zhang S; Guo Y; Gao J; Yang X
    J Cell Biochem; 2019 Apr; 120(4):6237-6249. PubMed ID: 30335900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stat3 activation in human endometrial and cervical cancers.
    Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
    Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. STAT3 Targets
    Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X
    Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β.
    Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C
    J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
    Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. S100A9 promotes the proliferation and migration of cervical cancer cells by inducing epithelial‑mesenchymal transition and activating the Wnt/β‑catenin pathway.
    Zha H; Li X; Sun H; Duan L; Yuan S; Li H; Li A; Gu Y; Zhao J; Xie J; Zhou L
    Int J Oncol; 2019 Jul; 55(1):35-44. PubMed ID: 31059008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
    Wang M; Wang W; Ding J; Wang J; Zhang J
    Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
    Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.